AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.14+0.01 (+3.82%)
Close on Nov 17, 2026Market cap $4.14MP/E –Yield –
AIM ImmunoTech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
AIM ImmunoTech's price to sales ratio was 45.3× on Nov 11, 2026, against 37.5× a year earlier. Over the last 5 years it ranged from 13.3× to 376.5×, with a median of 97.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 45.3× | +17.4 |
| 2025 | Dec 31, 2025 | 27.9× | −33.2 |
| 2024 | Dec 31, 2024 | 61.1× | −91.0 |
| 2023 | Dec 29, 2023 | 152.1× | +40.9 |
| 2022 | Dec 30, 2022 | 111.2× | −237.8 |
| 2021 | Dec 31, 2021 | 349.0× | −76.4 |
| 2020 | Dec 31, 2020 | 425.5× | +398.3 |
| 2019 | Apr 30, 2019 | 27.2× | −21.8 |
| 2018 | Dec 31, 2018 | 49.0× | +22.0 |
| 2017 | Dec 29, 2017 | 27.0× | −134.3 |
| 2016 | Dec 30, 2016 | 161.3× | +25.6 |
| 2015 | Dec 31, 2015 | 135.7× | −115.3 |
| 2014 | Dec 31, 2014 | 250.9× | −19.9 |
| 2013 | Dec 31, 2013 | 270.9× | +84.6 |
| 2012 | Dec 31, 2012 | 186.3× | +5.6 |
| 2011 | Dec 30, 2011 | 180.7× | – |
See a number that looks wrong?